Novo Nordisk shares rose by 3.5% on Monday, following the company’s withdrawal from a bidding war with Pfizer for Metsera, a US-based obesity drug maker. This move led to a significant increase in Novo Nordisk’s stock price, overcoming the previous day’s decline of nearly 16%.
Source: https://www.wsj.com/health/pharma/novo-nordisk-shares-rise-after-withdrawal-from-metsera-takeover-battle-89b46614